COAG Hemab Therapeutics Holdings, Inc.
Nasdaq · SEC CIK 2114044 · EDGAR
- Bought, last 12 months
- $55.46M 5 purchases by 1 insiders
- Sold, last 12 months
- $0 0 sales by 0 insiders
- Filings on record
- 9 since 2026-05-04, latest 2026-06-17 18:24
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | Dir, 10% | $55.46M | — |
| Novo Holdings A/S | 10% | — | — |
| MARAGANORE JOHN | Dir | — | — |
Transactions 8
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2026-06-17 18:24 | 2026-06-15+ | COAG | RA CAPITAL MANAGEMENT, L.P. | 10% | P - Purchase | $24.97 | +67.7K | 6.44M | +1% | +$1.69M |
| MI | 2026-05-21 16:20 | 2026-05-19+ | COAG | RA CAPITAL MANAGEMENT, L.P. | 10% | P - Purchase | $24.96 | +4,798 | 6.38M | +0.1% | +$119.8K |
| I | 2026-05-14 17:21 | 2026-05-12 | COAG | RA CAPITAL MANAGEMENT, L.P. | 10% | P - Purchase | $24.90 | +6,387 | 6.37M | +0.1% | +$159.0K |
| MI | 2026-05-11 17:44 | 2026-05-07+ | COAG | RA CAPITAL MANAGEMENT, L.P. | 10% | P - Purchase | $24.75 | +51.3K | 6.37M | +0.8% | +$1.27M |
| DMI | 2026-05-06 19:16 | 2026-05-04 | COAG | RA CAPITAL MANAGEMENT, L.P. | Dir, 10% | C - Cnv Deriv | — | +4.84M | 221.2K | New | — |
| DMI | 2026-05-06 19:16 | 2026-05-04+ | COAG | RA CAPITAL MANAGEMENT, L.P. | Dir, 10% | P - Purchase | $18.39 | +2.84M | 6.31M | +82% | +$52.22M |
| D | 2026-05-06 16:55 | 2026-05-04 | COAG | Novo Holdings A/S | 10% | C - Cnv Deriv | — | +4.18M | 4.18M | New | — |
| DM | 2026-05-04 16:20 | 2026-05-04 | COAG | MARAGANORE JOHN | Dir | C - Cnv Deriv | — | +35.9K | 35.9K | New | — |
Purchase Sale Sale after option exercise All abbreviations